Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Federal Workers’ Compensation Programs Adopt Opioid Policies

    by
    • Optum
    | May 17, 2017
    Tag Icon
    Opioids
    The Division of Federal Employee’s Compensation (DFEC) recently announced policy changes aimed at better managing and monitoring the usage of opioid medications utilized in treating Federal workers’ compensation claimants covered under their program. The policy changes will be implemented in phases, in August, and starting in August, and will apply to all Federal Employee Compensation Act (FECA) claimants where an opioid analgesic has not previously been prescribed within the last 180 days, if ever. Under the new policy, any prescribed opioid analgesic will be limited to a 60-day supply.


  • Florida Takes Regulatory Action On Compounds

    by
    • Optum Workers' Comp
    | May 11, 2017
    Tag Icon
    Compounded Medications
    The Florida Division of Workers’ Compensation (DWC) has adopted changes to their 2016 Healthcare Provider Reimbursement Manual implementing new requirements for the dispensing and reimbursement of compounded medications.


  • NEW - Drug Recall Expanded: Additional Lots of Phenobarbital recalled

    by
    • Optum Workers' Comp
    | May 09, 2017
    Tag Icon
    Medication Recall
    C.O. Truxton, Inc. is expanding their consumer-level, voluntary recall, previously issued on 4/21/17 for one lot of Phenobarbital 15 mg tablets that was mislabeled, to multiple lots as a precautionary measure.


  • Arkansas the latest to consider a state-specific drug formulary

    by
    | May 04, 2017
    Tag Icon
    Workers' Compensation, Formularies
    The Arkansas Workers’ Compensation Commission published notification of their intent to propose a new rule creating a Workers’ Compensation Drug Formulary. As proposed, the drug formulary would address all FDA-approved drugs prescribed for an accepted workers’ compensation claim filed after September 1, 2017, and at present does not address claims filed before this proposed effective date. The proposed formulary rule is intended to mirror the current Public Employee Claims Division (PECD) Workers’ Compensation Drug Formulary as the guideline for prescribing and dispensing of medications to an injured worker.






Subscribe

Stay informed by signing up to receive newsletters, alerts, insights and videos.
You can customize your content preferences after you subscribe.